Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - December 2012


Tablet Process Development and Validation and the application of QbD (3 day)

11 Dec 2012 - 13 Dec 2012 - County House, 221-241 Beckenham Road, Beckenham, BR3 4UF, Nr London



Bookmark and Share


This interactive workshop provides up-to-date, relevant and detailed information on the impact of Quality by Design (QbD) on the Development and Validation of tablet manufacturing processes. It will also study the identification and evaluation of Critical Product Attributes and Critical Process Parameters for tablets, and their implications for process control. We develop new concepts including the use of risk and process matrices for risk management. The latest ICH and FDA guidance on Quality by Design and Process Development, published in 2009, will be comprehensively reviewed. The hands-on workshop day will enable you to experience at first hand the impact of processing parameters on product quality.

By the end of the course, you will

·         Understand the relationship between the principles of QbD and tablet development and process validation in generic and new product development

·         Understand the relationship between material properties, formulation development and process development

·         Understand the processes commonly used to manufacture tablets and the factors which affect them. Recognise how to identify critical processing parameters, and how to incorporate into a process validation program

·         Understand the principles of PAT, how and where it can be most effectively deployed

·         Know the latest FDA thinking on Process Development including the three key steps of validation

·         Gain practical hands on experience of the impact of processing parameters on product quality on the small scale.

       Who should attend?
The  course  is designed  for people new  to Process Development,  and  those  requiring  a
refresher in the area.  It will also benefit Process Development experts wishing to extend
their understanding of why products processes can go wrong, and regulatory and quality
personnel who need to understand the development process better.  The course will include the latest FDA guidance on the development of generic products under QbD.

       Course outline:
Day 1: 
Morning - Product development 
• Principles of Quality by Design and the product development process 
• Linking material properties to formulation and processing behaviour 
• FDA Guidance on Process Validation 
Workshop session - Understanding Quality by Design 
  Afternoon -
Mixing, and dry granulation 
• Identifying potential Critical Process Parameters. 
• Unit processes 1 - Mixing and blending 
• Assessing blend uniformity. Sampling problems and practice 
Workshop session - blend assessment practical. Effect of material properties on    powder
 mixing behaviour 
Day 2: 
Morning - EFPIA Case study. Wet granulation 
• The new regulatory landscape. Q8, Q9 and Q10 and their impact on product and
process development. 
• EFPIA case study  -  what would a QbD regulatory submission look like? 
• Use of Process Matrices in process development 
• Developing wet granulation processes 
• Granulation endpoint control 
  Afternoon -
Drying, compression and film coating 
• Drying  -  techniques and process control 
• Compression  -  opportunities and threats! 
• Developing film coating processes 
• Round-up session 
 
Day 3: Practical 
• Blending 
• Granulation 
• Drying 
• Milling 
• Sieving 
• Compression 
• Granule and product characterisation 
 
NOTE 
Wherever possible participants should bring practical problems and examples which can
be reviewed on the course. The course will be highly participative and useful for people
with or without experience. Numbers are restricted to guarantee personal involvement.    

Ful  Course Speakers
Dr Michael Gamlen is Managing Director of Pharmaceutical Development Services Ltd, 
a pharmaceutical consultancy based in Nottingham (UK).
 

       Dr Dipankar Dey, PharmaTraining Ltd - Dipankar Dey recently joined PharmaTraining Ltd as Training Manager.

        Full Fee: 3 day course £1770.00 (+ VAT £354.00 if applicable, see notes on VAT)  

Discount of 10% applies for booking 8 weeks in advance. Discount of 10% applies for booking more than 1 delegate. Discount of 10% applies for booking more than 1 course.

Maximum discount received is 15%


Dr






Further information
Scientific News
Keeping Tumor Growth at Bay
Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
Improving Delivery of Poorly Soluble Drugs Using Nanoparticles
A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Nanoparticles Deliver Tumor Suppressors to Damaged Livers
UT Southwestern Medical Center chemists have successfully used synthetic nanoparticles to deliver tumor-suppressing therapies to diseased livers with cancer, an important hurdle scientists have been struggling to conquer.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
A New Type of Anticancer Agent
Success in the development of a ?-tubulin specific inhibitor.
Nanoparticles Proven Effective Against Antibiotic-Resistant “Superbugs”
In the ever-escalating evolutionary battle with drug-resistant bacteria, humans may soon have a leg up thanks to adaptive, light-activated nanotherapy developed by researchers at the University of Colorado Boulder.
Versatile New Molecule-Building Technique
Chemists at The Scripps Research Institute (TSRI) have devised a new and widely applicable technique for building potential drug molecules and other organic compounds.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!